LivaNova PLC Other Income and Expense
LivaNova PLC (LIVN) reported Other Income and Expense of -$23.83 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:NonoperatingIncomeExpense · last filed 2026-08-05
- LivaNova PLC nonoperating income (expense) for the quarter ending 2026-06-30 was -$23.83M.
- LivaNova PLC nonoperating income (expense) for the quarter ending 2026-03-31 was -$5.70M, a 149.89% decline year-over-year.
- LivaNova PLC nonoperating income (expense) for the quarter ending 2025-12-31 was -$2.35M, a 106.67% decline year-over-year.
- LivaNova PLC nonoperating income (expense) for the quarter ending 2025-09-30 was -$7.49M, a 130.33% decline year-over-year.
- LivaNova PLC nonoperating income (expense) for fiscal 2025 was -$2.68M, a 105.61% decline from fiscal 2024.
- LivaNova PLC nonoperating income (expense) for fiscal 2024 was $47.81M, a 3.66% increase from fiscal 2023.
- LivaNova PLC nonoperating income (expense) for fiscal 2023 was $46.13M.
| Period end | Nonoperating Income (Expense) 3 month | Nonoperating Income (Expense) 6 month | Nonoperating Income (Expense) 9 month | Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$23.83M 10-Q · filed 2026-08-05 | -$29.52M 10-Q · filed 2026-08-05 | -$31.87M derived: sum of 3 quarters · filed 2026-08-05 | -$39.37M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$5.70M 10-Q · filed 2026-05-06 | -$8.04M derived: sum of 2 quarters · filed 2026-05-06 | -$15.54M derived: sum of 3 quarters · filed 2026-05-06 | -$19.79M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$2.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$9.84M derived: sum of 2 quarters · filed 2026-02-25 | -$14.10M derived: sum of 3 quarters · filed 2026-08-05 | -$2.68M 10-K · filed 2026-02-25 |
| 2025-09-30 | -$7.49M 10-Q · filed 2025-11-05 | -$11.75M derived: sum of 2 quarters · filed 2026-08-05 | -$332.00K 10-Q · filed 2025-11-05 | $34.89M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$4.25M 10-Q · filed 2026-08-05 | $7.16M 10-Q · filed 2026-08-05 | $42.39M derived: sum of 3 quarters · filed 2026-08-05 | $67.09M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $11.42M 10-Q · filed 2026-05-06 | $46.64M derived: sum of 2 quarters · filed 2026-05-06 | $71.34M derived: sum of 3 quarters · filed 2026-05-06 | |
| 2024-12-31 | $35.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $59.93M derived: sum of 2 quarters · filed 2026-02-25 | $47.81M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $24.70M 10-Q · filed 2025-11-05 | $12.59M 10-Q · filed 2025-11-05 | ||
| 2023-12-31 | $46.13M 10-K · filed 2026-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |